Comparing Refractive and Visual Outcomes of MIGS and Traditional Surgeries
Status unconfirmed
Conditions studied: Glaucoma, Ocular Hypertension
In brief
The primary goal of this study is to evaluate refractive and visual outcomes in glaucoma patients who will be having either traditional glaucoma surgery or minimally invasive glaucoma surgery, also known as MIGS.
Key facts
- Study ID
- NCT03584958
- Run by
- Wills Eye
- People needed
- 150
- Starts
- 2018-08-01
- Expected to finish
- 2023-06-30
- Last updated by the study team
- 2022-03-29
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Diagnosis of glaucoma or ocular hypertension in the study eye(s) and are consented to receive any of the following procedures:
- Ab interno goniotomy surgery: Gonioscopy-assisted transluminal trabeculotomy (GATT) surgery to decrease intraocular pressure.
- Gelatin stent surgery: Subconjunctival stent (Xen) surgery to decrease intraocular pressure.
- Suprachoroidal stent and cataract surgery: Suprachoroidal stent (Cypass) to decrease intraocular pressure in combination with cataract surgery.
- Trabeculectomy surgery: Glaucoma filtering surgery to decrease intraocular pressure.
- Cataract surgery: Cataract surgery with no glaucoma procedure.
You may not qualify if…
- Patients with previous corneal ectasia or history of refractive procedures; patients who cannot fixate well due to poor vision (worse than 20/200)
Where it is running
- Wills Eye Hospital — Philadelphia, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.